Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 4/20 | 0.56 |
| ▸ | CTSL | P07711 | 1/20 | 0.56 |
| ▸ | CTSB | P07858 | 1/20 | 0.56 |
| ▸ | CTSS | P25774 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | MME | P08473 | 1/20 | 0.55 |
| ▸ | ECE1 | P42892 | 1/20 | 0.55 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.52 |
| ▸ | ELANE | P08246 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycolic Acid SCHEMBL12079265 | 1.00 | CTSK (0.56) | CTSKCTSLCTSBCTSSATM | |
| Glycolic Acid SCHEMBL901391 | 1.00 | CTSK (0.56) | CTSKCTSLCTSBCTSSATM | |
| SCHEMBL241564 | 0.94 | CTSK (0.61) | CTSKCTSLCTSBCTSSATM | |
| SCHEMBL856196 | 0.94 | CTSK (0.61) | CTSKCTSLCTSBCTSSATM | |
| SCHEMBL241565 | 0.94 | CTSK (0.61) | CTSKCTSLCTSBCTSSATM | |
| Hydrochloric Acid SCHEMBL7400990 | 0.92 | CTSK (0.60) | CTSKCTSLCTSBCTSSATM | |
| Hydrochloric Acid SCHEMBL7400995 | 0.92 | CTSK (0.60) | CTSKCTSLCTSBCTSSATM | |
| SCHEMBL7421757 | 0.88 | CTSK (0.62) | CTSKCTSLCTSBCTSSATM | |
| SCHEMBL22475275 | 0.88 | CTSK (0.62) | CTSKCTSLCTSBCTSSATM | |
| SCHEMBL8177898 | 0.88 | CTSK (0.62) | CTSKCTSLCTSBCTSSATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2811980-A1 | POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE | Cerulean Pharma Inc. (US) | 2014-12-17 | — | — | EP | disclosed |
| WO-2013115965-A1 | POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE | CERULEAN PHARMA INC. (US) | 2013-08-08 | — | — | WO | disclosed |
| EP-2503888-A1 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY | Cerulean Pharma Inc. (US) | 2012-10-03 | — | — | EP | disclosed |
| WO-2012050899-A1 | POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE | CERULEAN PHARMA INC. (US) | 2012-04-19 | — | — | WO | disclosed |
| WO-2012044832-A1 | METHODS OF TREATING A SUBJECT AND RELATED PARTICLES, POLYMERS AND COMPOSITIONS | FETZER OLIVER S (US) | 2012-04-05 | — | — | WO | disclosed |
| WO-2011119995-A2 | FORMULATIONS AND METHODS OF USE | CERULEAN PHARMA INC. (US) | 2011-09-29 | — | — | WO | disclosed |
| WO-2011063421-A1 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY | CERULEAN PHARMA INC. (US) | 2011-05-26 | — | — | WO | disclosed |